UBS Financial Ups Altera to 'Buy'

Analyst Thomas Thornhill says the upgrade is based on a 24% upside to his $22 12-month target

UBS Financial upgraded Altera (ALTR ) to buy from neutral.

Analyst Thomas Thornhill says the upgrade is based on a 24% upside to his $22 12-month target. At current prices, he doesn't strongly prefer either Altera or Xilinx over the other. He notes Altera's price-earnings ratio, vs. Xilinx, has declined from 1.3 times during the summer to 1 times, recently. Since then, both companies have similar outlooks; he thinks valuations should be roughly equal.

Thornhill expects Altera to report third-quarter sales of $210 million, up 2.5% -- the midpoint of its guided range. Also, Thornhill notes industry channel checks suggest that order and shipment patterns will support a few percent sales growth in the fourth quarter.

He sees 39 cents earnings per share in 2003 and 49 cents in 2004.

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE